Trading in JB Chemicals shares suspended from July 17, 2026 due to amalgamation scheme

Scheme filed with the NCLTStrategic TransactionsExplain this filing

JBCHEPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹2456.50

prior close

₹2460.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-1.1%+2.2% vs market

Pharmaceuticals peers, median of 167sector-0.2%+1.4% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Smallcap 250 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.4

15m

+0.7

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2-1.1+2.2-0.2+1.4

Next day

+1.9-0.4+2.3-0.3+2.2

-1.6-0.3-1.3-0.3-1.4

—-0.9—-1.3—

—-0.8—-0.8—

—-0.4—-0.7—

—-2.9—-2.9—

15d

—+0.1—-2.1—

—+0.6—-0.9—

—-1.5—-1.1—

—-1.9—-2.7—

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE has informed members that trading in equity shares of JB Chemicals and Pharmaceuticals will be suspended from July 17, 2026 (after close of trading on July 16, 2026) on account of a Scheme of Amalgamation. This indicates the company is set to merge with another entity under an approved scheme, pending completion of related formalities.

Likely market impact

Shareholders will not be able to trade shares after July 16, 2026; exit only through the swap ratio offered in the scheme.